JP2020527175A5 - - Google Patents

Download PDF

Info

Publication number
JP2020527175A5
JP2020527175A5 JP2020524667A JP2020524667A JP2020527175A5 JP 2020527175 A5 JP2020527175 A5 JP 2020527175A5 JP 2020524667 A JP2020524667 A JP 2020524667A JP 2020524667 A JP2020524667 A JP 2020524667A JP 2020527175 A5 JP2020527175 A5 JP 2020527175A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
haloalkyl
halo
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020527175A (ja
JP7067725B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/095973 external-priority patent/WO2019015583A1/en
Publication of JP2020527175A publication Critical patent/JP2020527175A/ja
Publication of JP2020527175A5 publication Critical patent/JP2020527175A5/ja
Application granted granted Critical
Publication of JP7067725B2 publication Critical patent/JP7067725B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524667A 2017-07-17 2018-07-17 Acc阻害剤としての新規な化合物およびそれらの使用 Expired - Fee Related JP7067725B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2017/093106 2017-07-17
CNPCT/CN2017/093106 2017-07-17
PCT/CN2018/095973 WO2019015583A1 (en) 2017-07-17 2018-07-17 NOVEL COMPOUNDS AND THEIR USES AS ACC INHIBITORS

Publications (3)

Publication Number Publication Date
JP2020527175A JP2020527175A (ja) 2020-09-03
JP2020527175A5 true JP2020527175A5 (enExample) 2021-07-26
JP7067725B2 JP7067725B2 (ja) 2022-05-16

Family

ID=65014996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524667A Expired - Fee Related JP7067725B2 (ja) 2017-07-17 2018-07-17 Acc阻害剤としての新規な化合物およびそれらの使用

Country Status (5)

Country Link
US (1) US10995099B2 (enExample)
EP (1) EP3655409B1 (enExample)
JP (1) JP7067725B2 (enExample)
CN (1) CN111201234A (enExample)
WO (2) WO2019015583A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3070525C (en) * 2017-07-26 2022-03-15 Nanjing Sanhome Pharmaceutical Co., Ltd. Compound as acc inhibitor and use thereof
JP7374233B2 (ja) 2019-07-02 2023-11-06 ▲広▼▲東▼▲東▼▲陽▼光▲薬▼▲業▼有限公司 立体配置を有するチエノピリミジン誘導体及び薬物におけるその応用
AR119594A1 (es) * 2019-08-09 2021-12-29 Gilead Sciences Inc Derivados de tienopirimidina como inhibidores acc y usos de los mismos
CN114555601B (zh) 2019-10-15 2024-04-02 勃林格殷格翰国际有限公司 新颖的四唑类
CN112778325A (zh) 2019-11-07 2021-05-11 南京瑞捷医药科技有限公司 一种acc抑制剂及其用途
CA3193607A1 (en) * 2020-10-14 2022-04-21 Boehringer Ingelheim International Gmbh Tetrazole derivatives as trpa1 inhibitors
US11661427B2 (en) * 2020-10-14 2023-05-30 Boehringer Ingelheim International Gmbh Tetrazole derivatives as TRPA1 inhibitors
CN116745299A (zh) * 2021-02-07 2023-09-12 正大天晴药业集团股份有限公司 噻吩并嘧啶衍生物
JP7565457B2 (ja) 2021-04-14 2024-10-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング TRPA1阻害剤としての3H,4H-チエノ-[2,3-d]ピリミジン-4-オン誘導体
CN114409664B (zh) * 2021-12-24 2023-07-18 河北威远生物化工有限公司 一种螺杂环四氢吡喃化合物及其制备方法和应用
CN114815020B (zh) * 2022-04-21 2023-09-22 岭南师范学院 一种高品质因数折射率传感器的设计方法及折射率传感器
CN116747321B (zh) * 2023-06-14 2025-09-05 厦门君德医药科技有限公司 一种接枝改性的介孔二氧化硅及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3628320B1 (en) 2011-11-11 2022-03-16 Gilead Apollo, LLC Acc inhibitors and uses thereof
JP6130909B2 (ja) * 2012-05-30 2017-05-17 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 生物農薬および殺虫剤を含む組成物
HK1221662A1 (zh) 2013-05-10 2017-06-09 Gilead Apollo, Llc Acc抑制剂和其用途
WO2015003879A1 (en) * 2013-07-08 2015-01-15 Syngenta Participations Ag Microbiocidal heterobicylic derivatives
CN105949197A (zh) * 2014-01-29 2016-09-21 苏州晶云药物科技有限公司 依鲁替尼的新晶型及其制备方法
GB201419102D0 (en) * 2014-10-27 2014-12-10 Imp Innovations Ltd Novel compounds
CA2972919A1 (en) 2015-01-09 2016-07-14 Gilead Apollo, Llc Acc inhibitor combination therapy for the treatment of non-alcoholic fatty liver disease
CN205115664U (zh) * 2015-10-15 2016-03-30 阳光能源(青海)有限公司 一种用于单晶炉的二次填料装置
CN106137971A (zh) * 2015-11-17 2016-11-23 南京瑞捷医药科技有限公司 一种他克莫司分散体及其缓释组合物及制备方法
CA3005900C (en) 2015-11-25 2023-10-31 Gilead Apollo, Llc Triazole acc inhibitors and uses thereof
MX2018006286A (es) 2015-11-25 2018-09-07 Gilead Apollo Llc Inhibidores de acc pirazolicos y usos de los mismos.
CN108699078A (zh) 2016-03-02 2018-10-23 吉利德阿波罗公司 噻吩并嘧啶二酮acc抑制剂的固体形式及其制备方法
PL3589636T3 (pl) * 2017-03-03 2024-02-19 Gilead Sciences, Inc. Sposoby wytwarzania inhibitorów acc i ich form stałych
WO2018228369A1 (zh) * 2017-06-15 2018-12-20 浙江海正药业股份有限公司 杂芳基并嘧啶酮类衍生物、其制备方法及其在医药上用途
CA3070525C (en) * 2017-07-26 2022-03-15 Nanjing Sanhome Pharmaceutical Co., Ltd. Compound as acc inhibitor and use thereof

Similar Documents

Publication Publication Date Title
JP2020527175A5 (enExample)
JP2012526728A5 (enExample)
JP2013509392A5 (enExample)
JP2006524222A5 (enExample)
JP2009533410A5 (enExample)
JP2012518634A5 (enExample)
JP2015516420A5 (enExample)
JP2017537940A5 (enExample)
JP2014508811A5 (enExample)
JP2015509535A5 (enExample)
JP2014051526A5 (enExample)
JP2015520140A5 (enExample)
JP2016503799A5 (enExample)
JP2015535839A5 (enExample)
JP2016540742A5 (enExample)
JP2016534134A5 (enExample)
JP2009143956A5 (enExample)
JP2013538802A5 (enExample)
JP2014500265A5 (enExample)
JP2016512505A5 (enExample)
JP2007530698A5 (enExample)
RU2017101829A (ru) Пиразоловые соединения в качестве модуляторов fshr и пути их применения
JP2017538689A5 (enExample)
JP2017505293A5 (enExample)
JP2013533253A5 (enExample)